JCM Figure table search 04
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kellogg, J. A.
Right arrow Articles by Smith, M. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kellogg, J. A.
Right arrow Articles by Smith, M. C.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, September 2001, p. 3373-3375, Vol. 39, No. 9
0095-1137/01/$04.00+0   DOI: 10.1128/JCM.39.9.3373-3375.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.

Identification of Streptococcus pneumoniae Revisited

James A. Kellogg,* David A. Bankert, Carol J. Elder, Joanne L. Gibbs, and Marie C. Smith

Clinical Microbiology Laboratory, York Hospital, York, Pennsylvania 17405

Received 6 April 2001/Returned for modification 16 May 2001/Accepted 12 June 2001

The sensitivities and specificities of several different diagnostic assays for Streptococcus pneumoniae were assessed using 99 clinical isolates of S. pneumoniae and 101 viridans streptococci and were as follows: Pneumoslide, 99 and 87%, respectively; Directigen, 100 and 85%, respectively; Phadebact, 100 and 98%, respectively; deoxycholate drop test, 99 and 98%, respectively; deoxycholate tube test, 100 and 99%, respectively; optochin, 99 and 98%, respectively; and Gram Positive Identification Card, 90 and 96%, respectively. Identification of clinical isolates of S. pneumoniae should be confirmed using one or more diagnostic assays with well-documented high (e.g., >= 95%) sensitivities and specificities.

* Corresponding author. Mailing address: Clinical Microbiology Laboratory, York Hospital, 1001 S. George St., York, PA 17405. Phone: (717) 851-2393. Fax: (717) 851-2707. E-mail: jkellogg{at}wellspan.org.

Journal of Clinical Microbiology, September 2001, p. 3373-3375, Vol. 39, No. 9
0095-1137/01/$04.00+0   DOI: 10.1128/JCM.39.9.3373-3375.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.


This article has been cited by other articles:



Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Antimicrob. Agents Chemother. Clin. Microbiol. Rev.
Clin. Vaccine Immunol. ALL ASM JOURNALS

Copyright © 2001 by the American Society for Microbiology. All rights reserved.